Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Nirlus

Nirlus?uq=XnI5dm0O
2006 FOUNDED
PRIVATE STATUS
Later Stage VC LATEST DEAL TYPE
1 INVESTORS
Description

Developer of devices designed to offer non-invasive blood glucose monitoring services. The company's devices use technologies for non-invasive analysis of chemical compositions of human blood, enabling patients to improve their health and wellbeing by being able to monitor blood sugar levels more frequently, thus getting a more favorable outcome and potentially longer lifespan.

Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Monitoring Equipment
Other Industries
Other Healthcare Technology Systems
Primary Office
  • Salzwiese 3
  • 23560 Lübeck
  • Germany

+49 0451 00000000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Nirlus’s full profile, request a free trial.

Nirlus Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Later Stage VC 01-Jan-2012 Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

Nirlus Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
EMBL Ventures Venture Capital Minority 000 0000 000000 0

Nirlus Executive Team (2)

Name Title Board
Seat
Contact
Info
Andrej Augustinov Co-Founder & Co-Chairman
Vera Herrmann Co-Founder & Board Member

Nirlus Board Members (5)

Name Representing Role Since Contact
Info
Andre Hoffmann Nirlus Board Member 000 0000
Andrej Augustinov Nirlus Co-Founder & Co-Chairman 000 0000
Ernst Peter Komrowski Nirlus Board Member 000 0000
Hannes Fehr Nirlus Co-Chairman 000 0000
Vera Herrmann Nirlus Co-Founder & Board Member 000 0000